China Shineway Pharmaceutical Group Limited China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited

2877

Rank in Stocks #10964
As an investment holding enterprise, China Shineway Pharmaceutical Group... As an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.
Share Price
$0.95177115
Last synced: 2026-10-16
Market Cap
$718.97M
Change (1 day)
-0.40%
Change (1 year)
-95.06%
Country
CN
Trade China Shineway Pharmaceutical Group Limited (2877)

Category

Healthcare
EPS for China Shineway Pharmaceutical Group Limited (2877)
EPS as of 2026 TTM: 0
According to China Shineway Pharmaceutical Group Limited latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for China Shineway Pharmaceutical Group Limited from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors